KEGG pathway | P value | Example of predicted targets |
---|---|---|
Ubiquitin mediated proteolysis | 2.15 × 10−10 |  |
Long-term potentiation | 1.67 × 10−9 | PRKCA*, CAMK4, GRIA1, PPP3CC, KRAS, CALM2*, GRIA2, PPP3CA, GRM1, RPS6KA3*, EP300*, GNAQ* |
Axon guidance | 1.32 × 10−7 | GSK3B*, ABLIM3, SEMA5A, EPHA5, ROCK2*, PAK7, ROBO2, SEMA3C*, SRGAP1*, PPP3CC, KRAS, EPHA7, PPP3CA, PTK2*, RASA1*, NFAT5*, EPHB4*, UNC5C, CFL2*, SEMA3D, SEMA3A*, PLXNC1*, EPHA4*, SEMA3E, UNC5D |
ErbB signaling | 7.04 × 10−7 |  |
Neurotrophin signaling | 7.35 × 10−7 | GSK3B, NTRK2*, CAMK4, CRK, SORT1*, NTRK3*, FRS2*, MAP3K1*, KRAS, CALM2*, JUN, MAPK8, SOS1*, RPS6KA3*, GAB1, AKT3*, CAMK2B, FOXO3, MAP2K1, PRDM4, RAP1B, MAP3K5 |
Insulin signaling | 8.72 × 10−7 |  |
Dopaminergic synapse | 1.56 × 10−6 | FOS, GSK3B*, PRKCA*, PPP2R5E, PPP2R3A, PPP2R2C, CREB5, DRD1, GRIA1, PPP3CC, CALM2*, GRIA2, PPP3CA, MAPK8, PPP2R2A, SCN1A, PPP2R3C, GNAQ, PPP2CB, AKT3*, CAMK2B, PPP1CB, GRIA3 |